We are live on ! Find out more
PDLI

PDL BioPharma, Inc.
PDLI

Delisted

PDLI was delisted on the 30th of December, 2020.

Back to rankings

Fund managers haven’t disclosed any holdings of PDLI yet.

PDLI Hedge Fund Activity: Q1 2026 in Review

6 of the 8,125 institutional investors tracked by Wall St. Rank reported a position in PDL BioPharma, Inc. (PDLI) for Q1 2026, worth a combined $29.2K — up 4.5% from $28K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of PDLI and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 1 added.

The largest buyer was Diversified Trust, adding an estimated $1.26K.

  • 6 institutional investors held PDL BioPharma, Inc. (PDLI) as of Q1 2026, down from 8 in Q4 2025.
  • Funds reported $29.2K of PDL BioPharma, Inc. stock for Q1 2026, up 4.5% quarter-over-quarter.
  • 0 funds opened new PDL BioPharma, Inc. positions in Q1 2026 and 1 closed out, a net change of -1 holder.
  • The largest PDL BioPharma, Inc. buyer in Q1 2026 was Diversified Trust, an estimated $1.26K added.

Based on aggregated 13F filings for Q1 2026.